Morris Milton Mayo Acquires Shares in Myomo, Inc.
Morris Milton Mayo purchased 78,704 shares of Myomo, Inc. on June 25, 2026.
Key Points
- Morris Milton Mayo acquired 78,704 shares of Myomo, Inc. on June 25, 2026, reflecting insider confidence.
- Shares of Myomo, Inc. traded at $1.14 on Saturday with a market cap of $39.8 million and a forward P/E ratio of -4.07.
- Ascendiant Capital maintained a 'buy' rating with a $10 target for Myomo, Inc. as of June 8, 2026.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Morris Milton Mayo, a notable insider, purchased 78,704 shares of Myomo, Inc. on June 25, 2026. This move indicates a potential vote of confidence in the company's future prospects.
Other Institutional Activity in Myomo, Inc.
Rosalind Advisors, Inc. grew its holdings by 7,500 shares, ending with 3,847,272 shares worth about $2,599,217. BlackRock, Inc. reduced its position by 24,389 shares, holding 1,688,390 shares valued at $1,140,675. Vanguard Capital Management LLC opened a new position with 1,144,324 shares worth $773,563. Geode Capital Management, LLC increased its stake by 121,830 shares, totaling 858,799 shares valued at $580,274. Jefferies Financial Group Inc. maintained its position at 704,275 shares, valued at $475,808.
Myomo, Inc. Stock Down 33.6%
Shares of NYSE American:MYO traded near $1.14 on Saturday. Myomo, Inc. has a market cap of approximately $39.8 million and a forward P/E ratio of -4.07, indicating it isn't currently profitable. The stock has a 52-week range between $0.60 and $2.38. It also has a 50-day moving average of $1.02 and a 200-day moving average of $0.92. The company's current ratio is 2.73, and its quick ratio is 2.19, with a debt-to-equity ratio of 210.65.
$MYO stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
In its latest financial results, Myomo, Inc. reported revenue of $41.2 million, reflecting a modest growth of 2.9%. The company posted a net margin of -36.7% and a return on equity of -98.5%. The next earnings announcement is scheduled for August 10, 2026.
Insider Buying and Selling at Myomo, Inc.
On June 25, 2026, several insiders, including Kirk Thomas, William Febbo, Morris Milton Mayo, Heather Getz, Joseph Manko Jr., and Thomas Aloysius Jr., each bought 78,704 shares. These transactions were not executed under a Rule 10b5-1 plan, suggesting they were discretionary buys.
Analysts Set New Price Targets
On June 8, 2026, Ascendiant Capital maintained a 'buy' rating for Myomo, Inc. with a price target of $10. The consensus among five analysts is a 'buy' recommendation, with a mean target price of $4.42.
About Myomo, Inc.
Myomo, Inc. is a healthcare company based in Burlington, Massachusetts, specializing in wearable medical robotics. The company designs and manufactures myoelectric orthotics to assist individuals with neuromuscular disorders. Its main product, MyoPro, helps support weak or paralyzed arms, enhancing daily functional activities. Myomo operates in the United States, Germany, and other international markets, reaching customers through various sales channels, including orthotics and prosthetics providers.
Bottom Line
Morris Milton Mayo's purchase of Myomo shares on June 25, 2026, is a noteworthy insider transaction. Investors often track such insider activities as they can hint at the confidence insiders have in the company's future. As a reminder, these transactions are reported after they occur and may not reflect current holdings.
Get Myomo, Inc. alerts
New 13F filings, insider trades, and analyst moves on $MYO, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.